within Pharmacolibrary.Drugs.ATC.A;

model A06AX04
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0.0,
    adminDuration  = 600,
    adminMass      = 0.29 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>A06AX04</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Linaclotide is a guanylate cyclase-C agonist used for the treatment of irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC) in adults. It increases intestinal fluid secretion and transit. Linaclotide is currently approved and used for these indications.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics in healthy adults—parameters estimated based on available clinical summaries as linaclotide is minimally absorbed following oral administration and systemic exposures are negligible.</p><h4>References</h4><ol><li><p>McCormack, PL (2014). Linaclotide: a review of its use in the treatment of irritable bowel syndrome with constipation. <i>Drugs</i> 74(1) 53–60. DOI:<a href=\"https://doi.org/10.1007/s40265-013-0157-5\">10.1007/s40265-013-0157-5</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/24293117/\">https://pubmed.ncbi.nlm.nih.gov/24293117</a></p></li><li><p>Love, BL, et al., &amp; Smith, LS (2014). Linaclotide: a novel agent for chronic constipation and irritable bowel syndrome. <i>American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists</i> 71(13) 1081–1091. DOI:<a href=\"https://doi.org/10.2146/ajhp130575\">10.2146/ajhp130575</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/24939497/\">https://pubmed.ncbi.nlm.nih.gov/24939497</a></p></li><li><p>Layer, P, &amp; Stanghellini, V (2014). Review article: Linaclotide for the management of irritable bowel syndrome with constipation. <i>Alimentary pharmacology &amp; therapeutics</i> 39(4) 371–384. DOI:<a href=\"https://doi.org/10.1111/apt.12604\">10.1111/apt.12604</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/24433216/\">https://pubmed.ncbi.nlm.nih.gov/24433216</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end A06AX04;
